Get the Stockscreener App
23.43
0.56%
0.1347
Innoviva Inc stock is traded at $23.43, with a volume of 300.32K.
It is up +0.56% in the last 24 hours and up +2.05% over the past month.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
See More
Previous Close:
$23.30
Open:
$23.54
24h Volume:
300.32K
Relative Volume:
0.40
Market Cap:
$1.74B
Revenue:
$425.13M
Net Income/Loss:
$271.17M
P/E Ratio:
7.6702
EPS:
3.0553
Net Cash Flow:
$195.80M
1W Performance:
+3.72%
1M Performance:
+2.05%
6M Performance:
+28.95%
1Y Performance:
+30.60%
1-Day Range:
$23.11
$23.63
1-Week Range:
$22.51
$23.63
52-Week Range:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
23.43 | 1.73B | 425.13M | 271.17M | 195.80M | 3.0553 |
VRTX
Vertex Pharmaceuticals Inc
|
447.16 | 113.44B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
773.08 | 81.68B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.00 | 45.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
329.75 | 43.88B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.75 | 35.25B | 606.42M | -1.28B | -997.58M | -6.403 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-26 | Initiated | BTIG Research | Buy |
| Sep-30-25 | Initiated | Goldman | Sell |
| Aug-11-25 | Initiated | Oppenheimer | Outperform |
| Jul-14-25 | Initiated | H.C. Wainwright | Buy |
| Jul-11-25 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
View All
Innoviva Inc Stock (INVA) Latest News
INVA PE Ratio & Valuation, Is INVA Overvalued - Intellectia AI
Earnings Report: Is Innoviva Inc likely to announce a buyback2026 Sector Moves & Verified Chart Pattern Signals - baoquankhu1.vn
Aug Levels: Will Innoviva Inc stock hit new highs in YEAR2026 Review & Fast Gain Stock Trading Tips - baoquankhu1.vn
Price-Driven Insight from (INVA) for Rule-Based Strategy - Stock Traders Daily
Working capital per share of Innoviva, Inc. – BX:HVE - TradingView
Book value per share of Innoviva, Inc. – BX:HVE - TradingView
Aug Mood: Should I invest in Innoviva Inc before earningsDollar Strength & Daily Entry Point Trade Alerts - baoquankhu1.vn
Net current asset value per share of Innoviva, Inc. – BX:HVE - TradingView
INVA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Innoviva (INVA) files 10-K/A adding Armata audited financials and new officer certifications - Stock Titan
Vanguard discloses 0% Innoviva holding (NASDAQ: INVA) - Stock Titan
INNOVIVA PB Ratio: 1.44 — 30% Below Median - GuruFocus
Risk Recap: What is the next catalyst for Innoviva IncBuy Signal & Daily Oversold Bounce Ideas - baoquankhu1.vn
Retail Trends: Is Innoviva Inc impacted by rising rates2026 Rallies & AI Enhanced Execution Alerts - baoquankhu1.vn
Innoviva (NASDAQ: INVA) ties big 2026 equity plan to strong 2025 results - Stock Titan
Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of "Moderate Buy" from Analysts - marketbeat.com
Is It Time To Revisit Innoviva (INVA) After Strong Multi Year Share Price Gains - Yahoo Finance
Oliver Luxxe Assets LLC Invests $1.69 Million in Innoviva - National Today
Oliver Luxxe Assets LLC Makes New $1.69 Million Investment in Innoviva, Inc. $INVA - MarketBeat
Aug Levels: Is Innoviva Inc likely to announce a buybackWeekly Stock Recap & Consistent Profit Trade Alerts - baoquankhu1.vn
Innoviva spotlights subgroup analysis from ATHOS-3 trial on thromboembolic events - Traders Union
Innoviva (NASDAQ:INVA) Stock Crosses Above Two Hundred Day Moving AverageHere's Why - MarketBeat
(INVA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Innoviva, Inc. (INVA): A bull case theory - MSN
Assessing Innoviva (INVA) Valuation After Strong Earnings Growth And Portfolio Expansion - Sahm
Forecast Cut: Whats the RSI of Innoviva Inc stockWeekly Trend Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
How Investors May Respond To Innoviva (INVA) Surging EPS From Continuing Operations - simplywall.st
Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report - Weekly Voice
Day Trade: Is Innoviva Inc a stock for growth or value investorsMarket Volume Report & Fast Gain Swing Alerts - baoquankhu1.vn
(INVA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Quantbot Technologies LP Lowers Stake in Innoviva, Inc. $INVA - MarketBeat
American Century Companies Inc. Boosts Stake in Innoviva, Inc. - National Today
American Century Companies Inc. Buys 284,253 Shares of Innoviva, Inc. $INVA - MarketBeat
Analysts Offer Predictions for Innoviva FY2027 Earnings - MarketBeat
Vanguard Group Inc. Sells 81,916 Shares of Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. $INVA Shares Bought by Royce & Associates LP - MarketBeat
HC Wainwright Has Bearish Forecast for Innoviva Q1 Earnings - MarketBeat
CVRX,INVA Dividends - Finviz
Innoviva, Inc. (INVA) Stock Analysis: With A 45% Potential Upside, Is It Time To Buy? - DirectorsTalk Interviews
Analysts Offer Insights on Healthcare Companies: Cybin (HELP), Twist Bioscience (TWST) and Innoviva (INVA) - The Globe and Mail
Profit Recap: Will Innoviva Inc benefit from current market trendsTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
INNOVIVA INC (NASDAQ:INVA) Emerges as a High-Growth Momentum Pick Using Minervini's Trend Template - ChartMill
Innoviva’s 2025 Earnings and NUZOLVENCE Launch Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
INVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Innoviva CEO Details 3-Part Growth Plan, $125M Buyback, and 2026 Catalysts at Oppenheimer Conference - Defense World
INVA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31Here's Why - Bitget
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 – Here’s Why - Insider Monkey
Is It Time To Reassess Innoviva (INVA) After Its Strong Multi Year Share Price Run - Yahoo Finance
Is It Too Late To Consider Innoviva (INVA) After Its Strong Multi‑Year Share Price Run? - simplywall.st
Innoviva (INVA) One Off Gain Driven 65.9% Margin Challenges Bullish Earnings Narratives - Sahm
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):